Nucleoside phosphoramidate prodrugs
US9085573B2 · kind B2 · utility
38Cited by
136References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 29, 2013 |
| Grant date | Jul 21, 2015 |
| Priority date | — |
| Expiry date | Aug 29, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are phosphoramidate prodrugs of nucleoside derivatives for the treatment of viral infections in mammals, which is a compound, its stereoisomer, salt (acid or basic addition salt), hydrate, solvate, or crystalline form thereof, represented by the following structure:Also disclosed are methods of treatment, uses, and processes for preparing each of which utilize the compound represented by formula I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.